The HRT Conversation Needs An Update

Welcome to The Longevity Playbook.

If you're here, you're already part of the High Performance Playbook community, which means you've been following along on mindset, money, and building a life that actually works. This is the other half of that equation: your body.

Because here's the truth. None of it matters if you're running on empty. The deals, the wins, the ambition, all of it is downstream of your health. A healthy person has a thousand goals. A sick person has one.

So I built this. A no-fluff newsletter on the stuff actually moving the needle right now: GLP-1s, peptides, longevity science, hormone optimization, and the protocols I'm personally testing through Kora MD®.

Real strategies, plain language, zero hype.

Same voice you already know. New focus. I'm not here to give you information you can Google or pull from ChatGPT. I'm here to give you the blueprint that real wellness professionals, longevity doctors, and athletes are using in 2026.

Let's get to work.

Hey ,

In 2002, a single study rewrote how an entire generation thought about hormone therapy.

The Women's Health Initiative reported that hormone therapy raised the risk of heart disease, stroke, and breast cancer.

Prescriptions collapsed almost overnight.

Millions of women stopped treatment.

A generation of physicians was trained to treat hormones as dangerous.

More than two decades later, the picture looks very different. Not because the data was wrong, but because of what got lost in how it was read.

It's worth understanding, whether you're a woman weighing menopause symptoms or a man hearing conflicting things about testosterone.

What the Original Study Missed

The women in that 2002 trial were, on average, in their mid-60s. Many were more than a decade past menopause when they started therapy, often on older oral formulations, a detail that turned out to matter enormously.

Later analysis revealed what's now called the timing hypothesis: the effects of hormone therapy depend heavily on when it's started. Beginning therapy near menopause, in your early 50s, produces a very different risk profile than starting it in your late 60s on already-aging blood vessels.

When researchers looked specifically at women who started therapy under 60 and within 10 years of menopause, the risks were far smaller than the headlines suggested. In that group, therapy didn't appear to harm the heart, and some analyses pointed to lower all-cause mortality. The original data was applied too broadly, when the reality was far more specific.

Where the Evidence Stands for Women

The current consensus, reflected in the position statements of major menopause organizations, is more balanced than the fear that replaced it. For healthy women under 60 and within about 10 years of menopause, with bothersome symptoms and no major contraindications:

• It's the most effective treatment available for hot flashes and night sweats, and it often improves sleep and quality of life.

• It's a first-line option for the vaginal and urinary symptoms of menopause, where low-dose local estrogen carries minimal systemic risk.

• It helps protect against early postmenopausal bone loss and fracture.

• For most women in this window, therapy for symptom relief carries low absolute risk, and the benefits often outweigh the harms.

The nuances still matter. Combined estrogen-progestogen therapy carries a small, duration-dependent increase in breast cancer risk. Oral estrogen raises clot and stroke risk more than transdermal (patch) forms. And it's not recommended purely to prevent heart disease or dementia, or generally started fresh after 65.

It isn't for everyone.

Women with a history of hormone-sensitive breast cancer, prior blood clots, or certain other conditions need a different path. The point isn't that hormone therapy is universally safe but that the blanket fear was never accurate.

Where the Evidence Stands for Men

Men have lived through a parallel story with testosterone.

For years, testosterone therapy carried a cloud of cardiovascular concern, based largely on smaller studies and regulatory caution. In 2023, the large TRAVERSE trial tested that directly in more than 5,000 men with low testosterone and existing heart disease or high cardiovascular risk.

Over roughly two years, testosterone therapy did not increase major cardiac events compared with placebo, and there was no increase in prostate cancer.

That's meaningful reassurance. It isn't the whole picture, though.

The same trial flagged higher rates of atrial fibrillation and acute kidney injury in the testosterone group, and a prespecified bone substudy found an unexpectedly higher fracture risk, a result that surprised researchers and ran counter to the older assumption that testosterone protects bone. None of this reverses the cardiovascular-safety message, and it’s exactly why monitoring remains essential.

The same discipline that applies to women applies here:

• It's appropriate for men with genuine symptoms and consistently low levels confirmed on repeat morning blood tests, not for "low-normal" numbers or as a general anti-aging tool.

• Men planning to conceive soon should avoid it, since it suppresses fertility.

• Men with active prostate cancer, uncontrolled sleep apnea, or unstable heart disease need specialist guidance.

• Long-term safety beyond a few years is still being studied.

The Real Lesson

The thread connecting both stories is the same: timing, individual context, and formulation determine whether these therapies help or harm.

Only a real evaluation can capture that whole picture.

If you're navigating menopause, or wondering whether your fatigue and low drive trace back to hormones, the right answer isn't fear and it isn't a quick prescription.

It's an actual assessment of your symptoms, your labs, your history, and your risk profile, made with a physician who knows the current evidence.

At Kora MD, that's the conversation we're built for.

Not a reflexive no inherited from a misread study.

Not a careless yes.

A clear-eyed look at whether hormone optimization makes sense for you, and how to do it safely if it does.

The science has moved forward.

Your care should reflect where it actually stands.

Use code LP75 for $75 off your first order at Kora MD.

👉 Get Your Free Consultation

Reply and tell me: what should I break down next?

To your health,

Austin L. Wright

Join my inner circle - Follow me on X for daily business breakdowns, lifestyle hacks, and a behind-the-scenes look at what my team and I are building.

Follow me on IG to see how I’m living the blueprint. I practice what I preach.

P.S.

• We’re always looking to improve and create better newsletters for you in the future. If you have any feedback or suggestions for future editions, I’d love to hear from you! Just reply directly to this email and give me some ideas for how you think we could make it better!
  

• If you’re reading this online, make sure you subscribe using the button below:

_{Disclaimer: The ideas shared in this newsletter are those of the author, and this is in no way intended to be medical, legal, or financial advice. Always do your own research and consult with licensed professionals.}